<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02588573</url>
  </required_header>
  <id_info>
    <org_study_id>EX-MKTG-61</org_study_id>
    <nct_id>NCT02588573</nct_id>
  </id_info>
  <brief_title>Overall Performance of a 1-day Silicone Hydrogel Lens When Habitual Soft Lens Wearers Are Refit</brief_title>
  <official_title>Overall Performance of a 1-day Silicone Hydrogel Lens When Habitual Soft Lens Wearers Are Refit</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Coopervision, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Coopervision, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of the study is to compare the overall subjective comfort profile over 8 hours
      of lens wear in two groups of habitual soft contact lens wearers (daily disposable hydrogel
      lenses and frequent replacement lenses) when refitted in to somofilcon A lenses.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This will be a prospective, single day, randomized, double-masked, non-dispensing,
      contralateral study. Participants were recruited into one of two groups - participants who
      habitually wore etafilcon A: daily disposable hydrogel lenses and participants who habitually
      wore frequent replacement lenses (FREQ).
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2015</start_date>
  <completion_date type="Actual">April 2016</completion_date>
  <primary_completion_date type="Actual">March 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Comfort</measure>
    <time_frame>8 hours</time_frame>
    <description>Subjective ratings for lens comfort of etafilcon A and somofilcon A. Scale 0-100, 0=cannot be worn, causes pain, 100=cannot be felt ever.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Comfort Preference</measure>
    <time_frame>Baseline and 8 hours</time_frame>
    <description>Lens preference in regards to comfort of etafilcon A and somofilcon A. Categories: Strongly prefer etafilcon A lens, slightly prefer etafilcon A lens, no preference, slightly prefer somofilcon A lens, strongly prefer somofilcon A lens</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Bulbar Hyperemia</measure>
    <time_frame>Baseline and 8 hours</time_frame>
    <description>Bulbar hyperemia examination using Efron scale 0-4, 0.5 steps, 0=normal, 4=severe.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Limbal Hyperemia</measure>
    <time_frame>Baseline and 8 hours</time_frame>
    <description>Limbal hyperemia examination using Efron scale 0-4, 0.5 steps, 0=normal, 4=severe.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Conjunctival Staining</measure>
    <time_frame>8 hours</time_frame>
    <description>Conjunctival staining was graded in each quadrant with scale 0-4, 0.5 steps, 0=normal, 4=severe of four areas:
N - Nasal, T - Temporal, S - Superior, I - Interior, C - Central</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Visual Acuity</measure>
    <time_frame>Baseline and 8 hours</time_frame>
    <description>High contrast visual acuity at high illumination was measured with each lens at each visit using a logMAR chart.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">103</enrollment>
  <condition>Myopia</condition>
  <arm_group>
    <arm_group_label>Etafilcon A (control)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Subjects in each of the habitual wearing groups will be randomized to wear either the test or control lens in either the left or right eye.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Somofilcon A (test)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Subjects in each of the habitual wearing groups will be randomized to wear either the test or control lens in either the left or right eye.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>etafilcon A (control)</intervention_name>
    <description>contact lens</description>
    <arm_group_label>Etafilcon A (control)</arm_group_label>
    <arm_group_label>Somofilcon A (test)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>somofilcon A (test)</intervention_name>
    <description>contact lens</description>
    <arm_group_label>Etafilcon A (control)</arm_group_label>
    <arm_group_label>Somofilcon A (test)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  A person is eligible for inclusion in the study if he/she:

               1. Is at least 17 years of age and has full legal capacity to volunteer;

               2. Has read and signed an information consent letter;

               3. Is willing and able to follow instructions and maintain the appointment schedule;

               4. Is correctable to a visual acuity of 20/40 or better (in each eye) with their
                  habitual correction or the assigned study lenses;

               5. Habitually wears either etafilcon A lens or any frequent replacement contact
                  lenses (as defined in 4.1.1);

               6. Habitually wear contact lenses with a power between -1.00 and -6.00D (Diopters)
                  (inclusive) in both eyes;

               7. Demonstrates an acceptable fit with the study lenses;

               8. Is usually able to wear contact lenses for at least 8 hours per day.

        Exclusion Criteria:

          -  A person will be excluded from the study if he/she:

               1. Is participating in any concurrent clinical or research study;

               2. Has any known active* ocular disease and/or infection;

               3. Has a systemic condition that in the opinion of the investigator may affect a
                  study outcome variable;

               4. Is using any systemic or topical medications that in the opinion of the
                  investigator may affect a study outcome variable;

               5. Has known sensitivity to the diagnostic substances (pharmaceuticals), such as
                  fluorescein dye, or products to be used in the study;

               6. Is aphakic;

               7. Has undergone refractive error surgery.

               8. Has participated in the previous somfofilcon A study (ORE# 20893)

                    -  For the purposes of this study, active ocular disease is defined as
                       infection or inflammation which requires therapeutic treatment. Mild (i.e.
                       not considered clinically relevant) lid abnormalities (blepharitis,
                       meibomian gland dysfunction, papillae), corneal and conjunctival staining
                       and dry eye are not considered active ocular disease. Neovascularization and
                       corneal scars are the result of previous hypoxia, infection or inflammation
                       and are therefore not active.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>17 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lyndon Jones, PhD, FCOptom</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre for Contact Lens Research</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Center for Contact Lens Research, University of Waterloo</name>
      <address>
        <city>Waterloo</city>
        <state>Ontario</state>
        <zip>N2L 3G1</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Waterloo</name>
      <address>
        <city>Waterloo</city>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>February 2019</verification_date>
  <study_first_submitted>October 22, 2015</study_first_submitted>
  <study_first_submitted_qc>October 26, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 28, 2015</study_first_posted>
  <results_first_submitted>January 30, 2017</results_first_submitted>
  <results_first_submitted_qc>February 5, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">February 8, 2019</results_first_posted>
  <last_update_submitted>February 5, 2019</last_update_submitted>
  <last_update_submitted_qc>February 5, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">February 8, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Myopia</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <pre_assignment_details>Of the 103 enrolled, 13 participants were not eligible due to screen failure. This reporting group includes 90 participants (180 eyes) belonging to 2 groups of 45 habitual wearers of either etafilcon A lens or frequent replacement lenses (FREQ). All participants were randomized to wear etafilcon A in one eye and somofilcon A in the fellow eye.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Habitual Etafilcon A Wearers</title>
          <description>Habitual wearers of etafilcon A were randomized to wear etafilcon A lens in one eye and somofilcon A lens in the other eye for 8 hours during the contralateral study</description>
        </group>
        <group group_id="P2">
          <title>Habitual FREQ Wearers</title>
          <description>Habitual wearers of other frequent replacement lenses (FREQ) were randomized to wear etafilcon A lens in one eye and somofilcon A lens in the other eye for 8 hours during the contralateral study.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="45"/>
                <participants group_id="P2" count="45"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Randomized Eye Etafilcon A</title>
              <participants_list>
                <participants group_id="P1" count="45"/>
                <participants group_id="P2" count="45"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Randomized Eye Somofilcon A</title>
              <participants_list>
                <participants group_id="P1" count="45"/>
                <participants group_id="P2" count="45"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="45"/>
                <participants group_id="P2" count="45"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Habitual Etafilcon A Wearers Wearing Etafilcon A/Somofilcon A</title>
          <description>Habitual wearers of etafilcon A were randomized to wear somofilcon A lens (test) and etafilcon A lens (control) in a contralateral design for 8 hours during the study.</description>
        </group>
        <group group_id="B2">
          <title>Habitual FREQ Wearers Wearing Etafilcon A/Somofilcon A</title>
          <description>Habitual wearers of frequent replacement lenses (FREQ) were randomized to wear somofilcon A lens (test) and etafilcon A lens (control) in a contralateral design for 8 hours during the study.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="45"/>
            <count group_id="B2" value="45"/>
            <count group_id="B3" value="90"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="25" lower_limit="17" upper_limit="55"/>
                    <measurement group_id="B2" value="25" lower_limit="17" upper_limit="63"/>
                    <measurement group_id="B3" value="25" lower_limit="17" upper_limit="63"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="35"/>
                    <measurement group_id="B2" value="37"/>
                    <measurement group_id="B3" value="72"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Comfort</title>
        <description>Subjective ratings for lens comfort of etafilcon A and somofilcon A. Scale 0-100, 0=cannot be worn, causes pain, 100=cannot be felt ever.</description>
        <time_frame>8 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Habitual Etafilcon A Wearers Randomized to Etafilcon A</title>
            <description>Habitual wearers of etafilcon A were randomized to wear somofilcon A lens (test) and etafilcon A lens (control) in a contralateral design.
etafilcon A (control): contact lens</description>
          </group>
          <group group_id="O2">
            <title>Habitual Etafilcon A Wearers Randomized to Somofilcon A</title>
            <description>Habitual wearers of etafilcon A were randomized to wear somofilcon A lens (test) and etafilcon A lens (control) in a contralateral design.
somofilcon A (test): contact lens</description>
          </group>
          <group group_id="O3">
            <title>Habitual FREQ Wearers Randomized to Etafilcon A</title>
            <description>Habitual wearers of frequent replacement lenses (FREQ) were randomized to wear somofilcon A lens (test) and etafilcon A lens (control) in a contralateral design.
etafilcon A (control): contact lens</description>
          </group>
          <group group_id="O4">
            <title>Habitual FREQ Wearers Randomized to Somofilcon A</title>
            <description>Habitual wearers frequent replacement lenses (FREQ) were randomized to wear somofilcon A lens (test) and etafilcon A lens (control) in a contralateral design.
somofilcon A (test): contact lens</description>
          </group>
        </group_list>
        <measure>
          <title>Comfort</title>
          <description>Subjective ratings for lens comfort of etafilcon A and somofilcon A. Scale 0-100, 0=cannot be worn, causes pain, 100=cannot be felt ever.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>eyes</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="45"/>
                <count group_id="O2" value="45"/>
                <count group_id="O3" value="45"/>
                <count group_id="O4" value="45"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>eyes</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="45"/>
                <count group_id="O2" value="45"/>
                <count group_id="O3" value="45"/>
                <count group_id="O4" value="45"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="83" spread="17"/>
                    <measurement group_id="O2" value="77" spread="22"/>
                    <measurement group_id="O3" value="83" spread="14"/>
                    <measurement group_id="O4" value="83" spread="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Comfort Preference</title>
        <description>Lens preference in regards to comfort of etafilcon A and somofilcon A. Categories: Strongly prefer etafilcon A lens, slightly prefer etafilcon A lens, no preference, slightly prefer somofilcon A lens, strongly prefer somofilcon A lens</description>
        <time_frame>Baseline and 8 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Habitual Etafilcon A Wearers - Baseline</title>
            <description>Habitual wearers of etafilcon A were randomized to wear somofilcon A lens (test) and etafilcon A lens (control) in a contralateral design.</description>
          </group>
          <group group_id="O2">
            <title>Habitual FREQ Wearers - Baseline</title>
            <description>Habitual wearers of frequent replacement lenses (FREQ) were randomized to wear somofilcon A lens (test) and etafilcon A lens (control) in a contralateral design.</description>
          </group>
          <group group_id="O3">
            <title>Habitual Etafilcon A Wearers - 8hrs</title>
            <description>Habitual wearers of etafilcon A were randomized to wear somofilcon A lens (test) and etafilcon A lens (control) in a contralateral design.</description>
          </group>
          <group group_id="O4">
            <title>Habitual FREQ Wearers - 8hrs</title>
            <description>Habitual wearers of frequent replacement lenses (FREQ) were randomized to wear somofilcon A lens (test) and etafilcon A lens (control) in a contralateral design.</description>
          </group>
        </group_list>
        <measure>
          <title>Comfort Preference</title>
          <description>Lens preference in regards to comfort of etafilcon A and somofilcon A. Categories: Strongly prefer etafilcon A lens, slightly prefer etafilcon A lens, no preference, slightly prefer somofilcon A lens, strongly prefer somofilcon A lens</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="45"/>
                <count group_id="O2" value="45"/>
                <count group_id="O3" value="45"/>
                <count group_id="O4" value="45"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Strongly Prefer Etafilcon A Lens</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="13"/>
                    <measurement group_id="O4" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Slightly Prefer Etafilcon A Lens</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14"/>
                    <measurement group_id="O2" value="10"/>
                    <measurement group_id="O3" value="11"/>
                    <measurement group_id="O4" value="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>No Preference</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12"/>
                    <measurement group_id="O2" value="19"/>
                    <measurement group_id="O3" value="5"/>
                    <measurement group_id="O4" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Slightly Prefer Somofilcon A Lens</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10"/>
                    <measurement group_id="O2" value="11"/>
                    <measurement group_id="O3" value="9"/>
                    <measurement group_id="O4" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Strongly Prefer Somofilcon A Lens</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="7"/>
                    <measurement group_id="O4" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Bulbar Hyperemia</title>
        <description>Bulbar hyperemia examination using Efron scale 0-4, 0.5 steps, 0=normal, 4=severe.</description>
        <time_frame>Baseline and 8 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Habitual Etafilcon A Wearers Randomized to Etafilcon A</title>
            <description>Habitual wearers of etafilcon A were randomized to wear somofilcon A lens (test) and etafilcon A lens (control) in a contralateral design.</description>
          </group>
          <group group_id="O2">
            <title>Habitual Etafilcon A Wearers Randomized to Somofilcon A</title>
            <description>Habitual wearers of etafilcon A were randomized to wear somofilcon A lens (test) and etafilcon A lens (control) in a contralateral design.</description>
          </group>
          <group group_id="O3">
            <title>Habitual FREQ Wearers Randomized to Etafilcon A</title>
            <description>Habitual wearers of frequent replacement lenses (FREQ) were randomized to wear somofilcon A lens (test) and etafilcon A lens (control) in a contralateral design.</description>
          </group>
          <group group_id="O4">
            <title>Habitual FREQ Wearers Randomized to Somofilcon A</title>
            <description>Habitual wearers of frequent replacement lenses (FREQ) were randomized to wear somofilcon A lens (test) and etafilcon A lens (control) in a contralateral design.</description>
          </group>
        </group_list>
        <measure>
          <title>Bulbar Hyperemia</title>
          <description>Bulbar hyperemia examination using Efron scale 0-4, 0.5 steps, 0=normal, 4=severe.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>eyes</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="45"/>
                <count group_id="O2" value="45"/>
                <count group_id="O3" value="45"/>
                <count group_id="O4" value="45"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>eyes</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="45"/>
                <count group_id="O2" value="45"/>
                <count group_id="O3" value="45"/>
                <count group_id="O4" value="45"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.3" spread="0.4"/>
                    <measurement group_id="O2" value="1.3" spread="0.4"/>
                    <measurement group_id="O3" value="1.2" spread="0.4"/>
                    <measurement group_id="O4" value="1.2" spread="0.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>8 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.3" spread="0.4"/>
                    <measurement group_id="O2" value="1.3" spread="0.4"/>
                    <measurement group_id="O3" value="1.2" spread="0.4"/>
                    <measurement group_id="O4" value="1.2" spread="0.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Limbal Hyperemia</title>
        <description>Limbal hyperemia examination using Efron scale 0-4, 0.5 steps, 0=normal, 4=severe.</description>
        <time_frame>Baseline and 8 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Habitual Etafilcon A Wearers Randomized to Etafilcon A</title>
            <description>Habitual wearers of etafilcon A were randomized to wear somofilcon A lens (test) and etafilcon A lens (control) in a contralateral design.</description>
          </group>
          <group group_id="O2">
            <title>Habitual Etafilcon A Wearers Randomized to Somofilcon A</title>
            <description>Habitual wearers of etafilcon A were randomized to wear somofilcon A lens (test) and etafilcon A lens (control) in a contralateral design.</description>
          </group>
          <group group_id="O3">
            <title>Habitual FREQ Wearers Randomized to Etafilcon A</title>
            <description>Habitual wearers of frequent replacement lenses (FREQ) were randomized to wear somofilcon A lens (test) and etafilcon A lens (control) in a contralateral design.</description>
          </group>
          <group group_id="O4">
            <title>Habitual FREQ Wearers Randomized to Somofilcon A</title>
            <description>Habitual wearers of frequent replacement lenses (FREQ) were randomized to wear somofilcon A lens (test) and etafilcon A lens (control) in a contralateral design.</description>
          </group>
        </group_list>
        <measure>
          <title>Limbal Hyperemia</title>
          <description>Limbal hyperemia examination using Efron scale 0-4, 0.5 steps, 0=normal, 4=severe.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>eyes</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="45"/>
                <count group_id="O2" value="45"/>
                <count group_id="O3" value="45"/>
                <count group_id="O4" value="45"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>eyes</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="45"/>
                <count group_id="O2" value="45"/>
                <count group_id="O3" value="45"/>
                <count group_id="O4" value="45"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.2" spread="0.5"/>
                    <measurement group_id="O2" value="1.2" spread="0.5"/>
                    <measurement group_id="O3" value="1.0" spread="0.4"/>
                    <measurement group_id="O4" value="1.0" spread="0.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>8 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.2" spread="0.4"/>
                    <measurement group_id="O2" value="1.3" spread="0.4"/>
                    <measurement group_id="O3" value="1.4" spread="0.5"/>
                    <measurement group_id="O4" value="1.3" spread="0.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Conjunctival Staining</title>
        <description>Conjunctival staining was graded in each quadrant with scale 0-4, 0.5 steps, 0=normal, 4=severe of four areas:
N - Nasal, T - Temporal, S - Superior, I - Interior, C - Central</description>
        <time_frame>8 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Habitual Etafilcon A Wearers Randomized to Etafilcon A</title>
            <description>Habitual wearers of etafilcon A were randomized to wear somofilcon A lens (test) and etafilcon A lens (control) in a contralateral design.</description>
          </group>
          <group group_id="O2">
            <title>Habitual Etafilcon A Wearers Randomized to Somofilcon A</title>
            <description>Habitual wearers of etafilcon A were randomized to wear somofilcon A lens (test) and etafilcon A lens (control) in a contralateral design.</description>
          </group>
          <group group_id="O3">
            <title>Habitual FREQ Wearers Randomized to Etafilcon A</title>
            <description>Habitual wearers of frequent replacement lenses (FREQ) were randomized to wear somofilcon A lens (test) and etafilcon A lens (control) in a contralateral design.</description>
          </group>
          <group group_id="O4">
            <title>Habitual FREQ Wearers Randomized to Somofilcon A</title>
            <description>Habitual wearers of frequent replacement lenses (FREQ) were randomized to wear somofilcon A lens (test) and etafilcon A lens (control) in a contralateral design.</description>
          </group>
        </group_list>
        <measure>
          <title>Conjunctival Staining</title>
          <description>Conjunctival staining was graded in each quadrant with scale 0-4, 0.5 steps, 0=normal, 4=severe of four areas:
N - Nasal, T - Temporal, S - Superior, I - Interior, C - Central</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>eyes</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="45"/>
                <count group_id="O2" value="45"/>
                <count group_id="O3" value="45"/>
                <count group_id="O4" value="45"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>eyes</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="45"/>
                <count group_id="O2" value="45"/>
                <count group_id="O3" value="45"/>
                <count group_id="O4" value="45"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Nasal</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.0" spread="0.8"/>
                    <measurement group_id="O2" value="1.1" spread="1.0"/>
                    <measurement group_id="O3" value="1.1" spread="1.0"/>
                    <measurement group_id="O4" value="1.4" spread="1.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Temporal</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.4" spread="0.5"/>
                    <measurement group_id="O2" value="1.1" spread="0.9"/>
                    <measurement group_id="O3" value="0.6" spread="0.6"/>
                    <measurement group_id="O4" value="1.4" spread="1.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Superior</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.3" spread="0.5"/>
                    <measurement group_id="O2" value="0.6" spread="0.8"/>
                    <measurement group_id="O3" value="0.2" spread="0.5"/>
                    <measurement group_id="O4" value="0.9" spread="0.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Inferior</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.6" spread="0.7"/>
                    <measurement group_id="O2" value="1.1" spread="1.0"/>
                    <measurement group_id="O3" value="0.6" spread="0.8"/>
                    <measurement group_id="O4" value="1.2" spread="1.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Visual Acuity</title>
        <description>High contrast visual acuity at high illumination was measured with each lens at each visit using a logMAR chart.</description>
        <time_frame>Baseline and 8 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Habitual Etafilcon A Wearers Randomized to Etafilcon A</title>
            <description>Habitual wearers of etafilcon A were randomized to wear somofilcon A lens (test) and etafilcon A lens (control) in a contralateral design.</description>
          </group>
          <group group_id="O2">
            <title>Habitual Etafilcon A Wearers Randomized to Somofilcon A</title>
            <description>Habitual wearers of etafilcon A were randomized to wear somofilcon A lens (test) and etafilcon A lens (control) in a contralateral design.</description>
          </group>
          <group group_id="O3">
            <title>Habitual FREQ Wearers Randomized to Etafilcon A</title>
            <description>Habitual wearers of frequent replacement lenses (FREQ) were randomized to wear somofilcon A lens (test) and etafilcon A lens (control) in a contralateral design.</description>
          </group>
          <group group_id="O4">
            <title>Habitual FREQ Wearers Randomized to Somofilcon A</title>
            <description>Habitual wearers of frequent replacement lenses (FREQ) were randomized to wear somofilcon A lens (test) and etafilcon A lens (control) in a contralateral design.</description>
          </group>
        </group_list>
        <measure>
          <title>Visual Acuity</title>
          <description>High contrast visual acuity at high illumination was measured with each lens at each visit using a logMAR chart.</description>
          <units>LogMAR</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>eyes</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="45"/>
                <count group_id="O2" value="45"/>
                <count group_id="O3" value="45"/>
                <count group_id="O4" value="45"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>eyes</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="45"/>
                <count group_id="O2" value="45"/>
                <count group_id="O3" value="45"/>
                <count group_id="O4" value="45"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.05" spread="0.07"/>
                    <measurement group_id="O2" value="-0.05" spread="0.09"/>
                    <measurement group_id="O3" value="-0.07" spread="0.06"/>
                    <measurement group_id="O4" value="-0.06" spread="0.08"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>8 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.06" spread="0.08"/>
                    <measurement group_id="O2" value="-0.06" spread="0.10"/>
                    <measurement group_id="O3" value="-0.07" spread="0.08"/>
                    <measurement group_id="O4" value="-0.06" spread="0.08"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>8 hours</time_frame>
      <desc>Adverse events will be monitored for during the follow-up visit.</desc>
      <group_list>
        <group group_id="E1">
          <title>Etafilcon A Lens (Control) Worn by Habitual Etafilcon A Grp</title>
          <description>Habitual wearers of etafilcon A were randomized to wear somofilcon A lens (test) and etafilcon A lens (control) in a contralateral design.</description>
        </group>
        <group group_id="E2">
          <title>Somofilcon A Lens (Test) Worn by Habitual Etafilcon A Grp</title>
          <description>Habitual wearers of etafilcon A were randomized to wear somofilcon A lens (test) and etafilcon A lens (control) in a contralateral design.</description>
        </group>
        <group group_id="E3">
          <title>Etafilcon A Lens (Control) Worn by Habitual FREQ Grp</title>
          <description>Habitual wearers of frequent replacement lenses (FREQ) were randomized to wear somofilcon A lens (test) and etafilcon A lens (control) in a contralateral design.</description>
        </group>
        <group group_id="E4">
          <title>Somofilcon A Lens (Test) Worn by Habitual FREQ Grp</title>
          <description>Habitual wearers of frequent replacement lenses (FREQ) were randomized to wear somofilcon A lens (test) and etafilcon A lens (control) in a contralateral design.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="45"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="45"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="45"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="45"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="45"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="45"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="45"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="45"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Senior Manager Global Medical Scientific Affairs</name_or_title>
      <organization>CooperVision Inc.</organization>
      <phone>925 621-3761</phone>
      <email>javega@coopervision.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

